Thomas H. Kean, Representative
buy disclosed on 18 Jun 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Worth researching
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
Thomas H. Kean, Representative
buy disclosed on 18 Jun 2026 via House STOCK Act disclosures
Gilbert Cisneros, Representative
buy disclosed on 9 Mar 2026 via House STOCK Act disclosures
Ritchie John Torres, Representative
buy disclosed on 20 Aug 2025 via House STOCK Act disclosures
Ritchie John Torres, Representative
sell disclosed on 20 Aug 2025 via House STOCK Act disclosures
Rob Bresnahan, Representative
buy disclosed on 8 May 2025 via House STOCK Act disclosures